Souhaitez-vous accéder aux communiqués récents ?

BERLIN, June 03, 2022 (GLOBE NEWSWIRE) -- Arbitrage is a technique used by publishers to get low quality website visitors to click on high value adverts. According to Trey Vanes, Chief Marketing...

Houston, TX, June 02, 2022 (GLOBE NEWSWIRE) -- NuProbe Global, a genomics and molecular diagnostics company, announces the close of its $50M fundraising, co-led by AstraZeneca-CICC Fund, CR-CP Life...

OTTAWA, June 01, 2022 (GLOBE NEWSWIRE) -- New polling data commissioned by CIRA suggests that while Canadians are learning to live with COVID-19, their time spent in front of a screen is still...

BURLINGTON, Mass., May 30, 2022 (GLOBE NEWSWIRE) -- Avid® (Nasdaq: AVID), the leading media tech innovator for cloud-based content workflows, today announced that its Board of Directors has...

BURLINGTON, Mass., May 25, 2022 (GLOBE NEWSWIRE) -- As unveiled yesterday during its 2022 Investor Day event at the Nasdaq MarketSite in New York City, Avid® (Nasdaq: AVID), the leading media tech...

Preclinical study results demonstrated the combination of SciSparc's CannAmide™ with Clearmind's MEAI has the potential to reduce alcohol consumption TEL AVIV, Israel, May 10, 2022 (GLOBE NEWSWIRE)...

Pre-clinical trials based on proprietary combination demonstrate significant suppressive effect on alcohol consumption TORONTO, May 10, 2022 (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (CSE: CMND,...

Allschwil, Switzerland – May 10, 2022 Idorsia Ltd (SIX: IDIA) today announced that ACT-539313, a selective orexin-1 receptor antagonist, did not show an improvement over placebo in reducing the...

Allschwil, Switzerland – May 10, 2022 Idorsia Ltd (SIX: IDIA) today announced that ACT-539313, a selective orexin-1 receptor antagonist, did not show an improvement over placebo in reducing the...

Pune, India, May 09, 2022 (GLOBE NEWSWIRE) -- The global automotive fuel cell market size is expected to grow from USD 1.73 billion in 2021 to USD 34.63 billion in 2028, according to a new report...